Implantica’s anti-reflux device shows positive two-year results

Implantica has unveiled positive two-year results for its RefluxStop device, an implant designed to manage gastro-esophageal reflux disease (GERD).

Results from the study, which were presented at the Association of Upper Gastrointestinal Surgery (AUGIS) of Great Britain and Ireland 2024 Conference, demonstrate a 90.9% improvement in quality of life for patients living with the condition.